Translational Behavioral Medicine

, Volume 3, Issue 4, pp 392–401

A systematic review of eHealth cancer prevention and control interventions: new technology, same methods and designs?

  • Michael A Sanchez
  • Borsika A Rabin
  • Bridget Gaglio
  • Michelle Henton
  • M Khair Elzarrad
  • Peyton Purcell
  • Russell E Glasgow
systematic review

DOI: 10.1007/s13142-013-0224-1

Cite this article as:
Sanchez, M.A., Rabin, B.A., Gaglio, B. et al. Behav. Med. Pract. Policy Res. (2013) 3: 392. doi:10.1007/s13142-013-0224-1

Abstract

There has been a recent surge of eHealth programs in cancer and other content areas, but few reviews have focused on the methodologies and designs employed in these studies. We conducted a systematic review of studies on eHealth interventions on cancer prevention and control published between 2001 and 2010 applying the Pragmatic Explanatory Continuum Indicator Summary (PRECIS) criteria and external validity components from the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework. We identified 113 studies that focused on cancer prevention and control of eHealth interventions. Most studies fell midway along the explanatory/pragmatic trial continuum, but few reported on various practical feasibility criteria for translation. Despite vast interest in cancer eHealth and the applied nature of this field, few studies considered key external validity issues. There is a need for use of alternative pragmatic study designs and transparent reporting of external validity components to produce more rapid and generalizable results.

Keywords

eHealthPragmatic trialsSystematic reviewDesignPRECISExternal validityRE-AIM framework

Copyright information

© Society of Behavioral Medicine 2013

Authors and Affiliations

  • Michael A Sanchez
    • 1
  • Borsika A Rabin
    • 2
  • Bridget Gaglio
    • 3
  • Michelle Henton
    • 2
  • M Khair Elzarrad
    • 1
    • 4
  • Peyton Purcell
    • 5
  • Russell E Glasgow
    • 1
  1. 1.National Cancer InstituteBethesdaUSA
  2. 2.CRN Cancer Communication Research Center, Kaiser Permanente ColoradoDenverUSA
  3. 3.Mid-Atlantic Permanente Research Institute Kaiser Permanente Mid-Atlantic StatesRockvilleUSA
  4. 4.Food and Drug Administration, Interagency Oncology Task Force (IOTF) Fellowship-Cancer Prevention Fellow, National Cancer InstituteBethesdaUSA
  5. 5.Clinical Research Directorate/CMRP, SAIC-Frederick, Inc., National Laboratory for Cancer ResearchFrederickUSA